...
首页> 外文期刊>Clinical Biochemistry >Interference of hydroxyphenylpyruvic acid, hydroxyphenyllactic acid and tyrosine on routine serum and urine clinical chemistry assays; implications for biochemical monitoring of patients with alkaptonuria treated with nitisinone
【24h】

Interference of hydroxyphenylpyruvic acid, hydroxyphenyllactic acid and tyrosine on routine serum and urine clinical chemistry assays; implications for biochemical monitoring of patients with alkaptonuria treated with nitisinone

机译:羟基苯基吡咯酸,羟基烯丙基酸和酪氨酸对常规血清和尿液临床化学测定的干扰; 用核酮处理的碱性尿素患者生物化学监测的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: We have assessed the effect of elevated concentrations of hydroxyphenylpyruvic acid (HPPA), hydroxyphenyllactic acid (HPLA) and tyrosine, on a range of chemistry tests in serum and urine to explore the potential for chemical interference on routine laboratory analyses in patients with alkaptonuria (AKU) treated with nitisinone and similarly implications for patients with hereditary tyrosinemia type 1 (HT-1).
机译:目的:我们已经评估了浓度浓度浓度浓度浓度的羟基吡咯酸(HPPA),羟基苯丙烯酸(HPLA)和酪氨酸,在血清和尿液中的一系列化学试验中,探讨了持有人类患者患者常规实验室分析的化学干扰的可能性 (aku)用核酮治疗,对遗传性酪氨酸血症1型(HT-1)的患者同样影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号